Abstract 974: Phase II trial of the Wee1 inhibitor adavosertib in advanced refractory solid tumors with CCNE1 amplification
Fu, Siqing, Yao, Shuyang, Yuan, Yuan, Previs, Rebecca A., Elias, Anthony D., Carvajal, Richard, George, Thomas J., Yuan, Ying, Yamamura, Yuko, Westin, Shannon, Xing, Yan, Dumbrava, Ecaterina E. Ileana, Karp, Daniel D., Piha-Paul, Sarina A., Tsimberidou, Apostolia M., Rodon, Jordi, Takebe, Naoko, Kunos, Charles, Lu, Karen, Keyomarsi, Khanda, Meric-Bernstam, Funda
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article